ACE2: the molecular doorway to SARS-CoV-2

被引:0
|
作者
Miriam Marlene Medina-Enríquez
Sandra Lopez-León
José Alberto Carlos-Escalante
Zuleika Aponte-Torres
Angelica Cuapio
Talia Wegman-Ostrosky
机构
[1] Universidad de Barcelona,Facultad de Farmacia
[2] Novartis Pharmaceuticals Corporation,Global Drug Development
[3] Universidad Nacional Autónoma de México,PECEM (MD/PhD), Facultad de Medicina
[4] MS Epidemiology Consultant,Center of Infectious Medicine
[5] Karolinska Institutet,Department of Basic Research
[6] Instituto Nacional de Cancerología,undefined
来源
关键词
ACE2; SARS-CoV-2; COVID-19; Coronavirus;
D O I
暂无
中图分类号
学科分类号
摘要
The angiotensin-converting enzyme 2 (ACE2) is the host functional receptor for the new virus SARS-CoV-2 causing Coronavirus Disease 2019. ACE2 is expressed in 72 different cell types. Some factors that can affect the expression of the ACE2 are: sex, environment, comorbidities, medications (e.g. anti-hypertensives) and its interaction with other genes of the renin-angiotensin system and other pathways. Different factors can affect the risk of infection of SARS-CoV-2 and determine the severity of the symptoms. The ACE2 enzyme is a negative regulator of RAS expressed in various organ systems. It is with immunity, inflammation, increased coagulopathy, and cardiovascular disease. In this review, we describe the genetic and molecular functions of the ACE2 receptor and its relation with the physiological and pathological conditions to better understand how this receptor is involved in the pathogenesis of COVID-19. In addition, it reviews the different comorbidities that interact with SARS-CoV-2 in which also ACE2 plays an important role. It also describes the different factors that interact with the virus that have an influence in the expression and functional activities of the receptor. The goal is to provide the reader with an understanding of the complexity and importance of this receptor.
引用
收藏
相关论文
共 50 条
  • [31] Advances in developing ACE2 derivatives against SARS-CoV-2
    Zhang, Haoran
    Lv, Panjing
    Jiang, Jingrui
    Liu, Yahui
    Yan, Ruixi
    Shu, Sainan
    Hu, Bing
    Xiao, Han
    Cai, Kun
    Yuan, Shuai
    Li, Yan
    LANCET MICROBE, 2023, 4 (05): : e369 - e378
  • [32] The role of SARS-CoV-2 target ACE2 in cardiovascular diseases
    Zhu, Hanzhao
    Zhang, Liyun
    Ma, Yubo
    Zhai, Mengen
    Xia, Lin
    Liu, Jincheng
    Yu, Shiqiang
    Duan, Weixun
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (03) : 1342 - 1349
  • [33] Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor
    Li, Yanwei
    Zhou, Wei
    Yang, Li
    You, Ran
    PHARMACOLOGICAL RESEARCH, 2020, 157
  • [34] Expression pattern and function of SARS-CoV-2 receptor ACE2
    Li, Ruiting
    Qin, Chengfeng
    BIOSAFETY AND HEALTH, 2021, 3 (06) : 312 - 318
  • [35] ACE2: The Major Cell Entry Receptor for SARS-CoV-2
    Filippo Scialo
    Aurora Daniele
    Felice Amato
    Lucio Pastore
    Maria Gabriella Matera
    Mario Cazzola
    Giuseppe Castaldo
    Andrea Bianco
    Lung, 2020, 198 : 867 - 877
  • [37] ACE2: The Major Cell Entry Receptor for SARS-CoV-2
    Scialo, Filippo
    Daniele, Aurora
    Amato, Felice
    Pastore, Lucio
    Matera, Maria Gabriella
    Cazzola, Mario
    Castaldo, Giuseppe
    Bianco, Andrea
    LUNG, 2020, 198 (06) : 867 - 877
  • [38] ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
    Saponaro, Federica
    Rutigliano, Grazia
    Sestito, Simona
    Bandini, Lavinia
    Storti, Barbara
    Bizzarri, Ranieri
    Zucchi, Riccardo
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [39] Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets?
    Campbell, Robert A.
    Boilard, Eric
    Rondina, Matthew T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (01) : 46 - 50
  • [40] Endocrine Significance of SARS-CoV-2's Reliance on ACE2
    Lazartigues, Eric
    Qadir, Mirza Muhammad Fahd
    Mauvais-Jarvis, Franck
    ENDOCRINOLOGY, 2020, 161 (09)